DarioHealth Corp. Files 8-K on Shareholder Votes
Ticker: DRIO · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
DarioHealth Corp. filed an 8-K for a shareholder vote - details to follow.
AI Summary
DarioHealth Corp. filed an 8-K on April 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details about the specific proposals voted upon or the outcomes.
Why It Matters
This filing indicates that DarioHealth Corp. held a shareholder vote, which could pertain to significant corporate decisions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- April 28, 2025 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of DarioHealth Corp. security holders?
The filing does not specify the exact matters submitted for a vote.
When was the report filed?
The report was filed on April 28, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 322 W. 57th St, #33B, New York, New York 10019.
What is the company's telephone number?
The issuer's telephone number is 972-4-770-6377.
What was the former name of DarioHealth Corp.?
The former name of the company was LabStyle Innovations Corp.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding DarioHealth Corp. (DRIO).